David R. Epstein has served as a member of our board of directors since February 2024. Mr. Epstein also serves as a board member at Valo Health, LLC. He is a Director at the non-profit Three Opinions Foundation Inc and at South Florida’s Pelican Harbor Seabird Station. Mr. Epstein previously served as the Chief Executive Officer and a member of the board of directors of Seagen Inc. from November 2022 until Seagen’s acquisition by Pfizer Inc. in December 2023. From October 2021 to December 2023, Mr. Epstein served on the board of directors of OPY Acquisition Corp. I. From June 2022 to June 2023, Mr. Epstein served as a member of the board of directors of Senti Biosciences, Inc. and was previously a member of the board of Senti’s predecessor, Dynamics Special Purpose Corp. since March 2021. From March 2017 to February 2023, he served as a director at Evelo Biosciences, Inc., including as the Chair of its board of directors from September 2019 to June 2022. From 2017 until October 2022, Mr. Epstein was a consultant and executive partner at Flagship Pioneering. From May 2019 to October 2022, Mr. Epstein served on the board of directors and as Chairman of Axcella Health Inc. (formerly Axcella Therapeutics) and, from January 2017 to October 2022, Mr. Epstein served on the board of directors of Rubius Therapeutics, Inc., he served on the board of directors of Seer, Inc. From 2010 to mid-2016, he served as the Chief Executive Officer of Novartis Pharmaceuticals, a division of Novartis AG. Previously, he started and led Novartis’ Oncology and Molecular Diagnostic units. Under his leadership, Norvartis’ oncology business grew to the second largest in the world. Early in his career, he was an associate in the strategy practice of consulting firm Booz, Allen and Hamilton. Mr. Epstein holds a B.S. in pharmacy from Rutgers University College of Pharmacy and an M.B.A. in finance and marketing from Columbia University Graduate School of Business.
Committee Composition
Director Name | Audit Committee | Compensation Committee | Nominating and Corporate Governance Committee |
---|---|---|---|
Peter J. Barris | Member of the Audit Committee | Chairperson of the Compensation Committee | |
Eric D. Belcher | Chairperson of the Audit Committee | ||
Jennifer A. Doudna, Ph.D. | Member of the Nominating and Corporate Governance Committee | ||
David Epstein | |||
Wayne A.I. Frederick, M.D. | Member of the Audit Committee | ||
Scott Gottlieb, M.D. | Member of the Nominating and Corporate Governance Committee | ||
Theodore J. Leonsis | Chairperson of the Nominating and Corporate Governance Committee | ||
Nadja West, M.D. | Member of the Compensation Committee |